collection
https://read.qxmd.com/read/33332150/2020-acc-aha-guideline-for-the-management-of-patients-with-valvular-heart-disease-a-report-of-the-american-college-of-cardiology-american-heart-association-joint-committee-on-clinical-practice-guidelines
#21
JOURNAL ARTICLE
Catherine M Otto, Rick A Nishimura, Robert O Bonow, Blase A Carabello, John P Erwin, Federico Gentile, Hani Jneid, Eric V Krieger, Michael Mack, Christopher McLeod, Patrick T O'Gara, Vera H Rigolin, Thoralf M Sundt, Annemarie Thompson, Christopher Toly
No abstract text is available yet for this article.
February 2, 2021: Circulation
https://read.qxmd.com/read/33184265/delirium
#22
REVIEW
Jo Ellen Wilson, Matthew F Mart, Colm Cunningham, Yahya Shehabi, Timothy D Girard, Alasdair M J MacLullich, Arjen J C Slooter, E Wesley Ely
Delirium, a syndrome characterized by an acute change in attention, awareness and cognition, is caused by a medical condition that cannot be better explained by a pre-existing neurocognitive disorder. Multiple predisposing factors (for example, pre-existing cognitive impairment) and precipitating factors (for example, urinary tract infection) for delirium have been described, with most patients having both types. Because multiple factors are implicated in the aetiology of delirium, there are likely several neurobiological processes that contribute to delirium pathogenesis, including neuroinflammation, brain vascular dysfunction, altered brain metabolism, neurotransmitter imbalance and impaired neuronal network connectivity...
November 12, 2020: Nature Reviews. Disease Primers
https://read.qxmd.com/read/33160639/clinical-management-of-hyperkalemia
#23
REVIEW
Biff F Palmer, Juan Jesus Carrero, Deborah J Clegg, Gates B Colbert, Michael Emmett, Steven Fishbane, Debra J Hain, Edgar Lerma, Macaulay Onuigbo, Anjay Rastogi, Simon D Roger, Bruce S Spinowitz, Matthew R Weir
Hyperkalemia is an electrolyte abnormality with potentially life-threatening consequences. Despite various guidelines, no universally accepted consensus exists on best practices for hyperkalemia monitoring, with variations in precise potassium (K+ ) concentration thresholds or for the management of acute or chronic hyperkalemia. Based on the available evidence, this review identifies several critical issues and unmet needs with regard to the management of hyperkalemia. Real-world studies are needed for a better understanding of the prevalence of hyperkalemia outside the clinical trial setting...
November 4, 2020: Mayo Clinic Proceedings
https://read.qxmd.com/read/33215938/2020-aha-acc-guideline-for-the-diagnosis-and-treatment-of-patients-with-hypertrophic-cardiomyopathy-executive-summary-a-report-of-the-american-college-of-cardiology-american-heart-association-joint-committee-on-clinical-practice-guidelines
#24
REVIEW
Steve R Ommen, Seema Mital, Michael A Burke, Sharlene M Day, Anita Deswal, Perry Elliott, Lauren L Evanovich, Judy Hung, José A Joglar, Paul Kantor, Carey Kimmelstiel, Michelle Kittleson, Mark S Link, Martin S Maron, Matthew W Martinez, Christina Y Miyake, Hartzell V Schaff, Christopher Semsarian, Paul Sorajja
Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. Methods A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases...
December 22, 2020: Circulation
https://read.qxmd.com/read/33144515/international-consensus-guidance-for-management-of-myasthenia-gravis-2020-update
#25
REVIEW
Pushpa Narayanaswami, Donald B Sanders, Gil Wolfe, Michael Benatar, Gabriel Cea, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L Kuntz, Janice Massey, Arthur Melms, Hiroyuki Murai, Michael Nicolle, Jacqueline Palace, David Richman, Jan Verschuuren
OBJECTIVE: To update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature. METHODS: In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. The RAND/UCLA appropriateness method was used to develop consensus recommendations pertaining to 7 treatment topics. In February 2019, the international panel was reconvened with the addition of one member to represent South America...
January 19, 2021: Neurology
https://read.qxmd.com/read/33093137/imaging-review-of-paraneoplastic-neurologic-syndromes
#26
REVIEW
A A Madhavan, C M Carr, P P Morris, E P Flanagan, A L Kotsenas, C H Hunt, L J Eckel, E P Lindell, F E Diehn
Paraneoplastic syndromes are systemic reactions to neoplasms mediated by immunologic or hormonal mechanisms. The most well-recognized paraneoplastic neurologic syndrome, both clinically and on imaging, is limbic encephalitis. However, numerous additional clinically described syndromes affect the brain, spinal cord, and peripheral nerves. Many of these syndromes can have imaging findings that, though less well described, are important in making the correct diagnosis. Moreover, imaging in these syndromes frequently mimics more common pathology, which can be a diagnostic challenge for radiologists...
December 2020: AJNR. American Journal of Neuroradiology
https://read.qxmd.com/read/33097308/hepatic-encephalopathy-novel-insights-into-classification-pathophysiology-and-therapy
#27
REVIEW
Christopher F Rose, Piero Amodio, Jasmohan S Bajaj, Radha Krishan Dhiman, Sara Montagnese, Simon D Taylor-Robinson, Hendrik Vilstrup, Rajiv Jalan
Hepatic encephalopathy (HE) is a frequent and serious complication of both chronic liver disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric abnormalities, from subclinical changes (mild cognitive impairment) to marked disorientation, confusion and coma. The clinical and economic burden of HE is considerable, and it contributes greatly to impaired quality of life, morbidity and mortality. This review will critically discuss the latest classification of HE, as well as the pathogenesis and pathophysiological pathways underlying the neurological decline in patients with end-stage liver disease...
October 20, 2020: Journal of Hepatology
https://read.qxmd.com/read/32928750/hepatorenal-syndrome-pathophysiology-diagnosis-and-management
#28
REVIEW
Douglas A Simonetto, Pere Gines, Patrick S Kamath
Hepatorenal syndrome (HRS), the extreme manifestation of renal impairment in patients with cirrhosis, is characterized by reduction in renal blood flow and glomerular filtration rate. Hepatorenal syndrome is diagnosed when kidney function is reduced but evidence of intrinsic kidney disease, such as hematuria, proteinuria, or abnormal kidney ultrasonography, is absent. Unlike other causes of acute kidney injury (AKI), hepatorenal syndrome results from functional changes in the renal circulation and is potentially reversible with liver transplantation or vasoconstrictor drugs...
September 14, 2020: BMJ: British Medical Journal
https://read.qxmd.com/read/32719177/al-amyloidosis-advances-in-diagnosis-and-management
#29
REVIEW
Youngil Koh
Light chain (AL) amyloidosis is a disease in which malignant plasma cell clones affect multiple organs including the heart and kidney. The mechanism for organ function deterioration in AL amyloidosis differs from multiple myeloma. Thus, not all agents used to treat multiple myeloma shows similar efficacy in AL amyloidosis. In AL amyloidosis, both hematologic and organ responses after treatment are important to improve the clinical outcome. Especially, improving heart function is one of the key aspects in the treatment of AL amyloidosis...
July 31, 2020: Blood Research
https://read.qxmd.com/read/32409703/diabetic-ketoacidosis
#30
REVIEW
Ketan K Dhatariya, Nicole S Glaser, Ethel Codner, Guillermo E Umpierrez
Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes mellitus. A diagnosis of DKA is confirmed when all of the three criteria are present - 'D', either elevated blood glucose levels or a family history of diabetes mellitus; 'K', the presence of high urinary or blood ketoacids; and 'A', a high anion gap metabolic acidosis. Early diagnosis and management are paramount to improve patient outcomes. The mainstays of treatment include restoration of circulating volume, insulin therapy, electrolyte replacement and treatment of any underlying precipitating event...
May 14, 2020: Nature Reviews. Disease Primers
https://read.qxmd.com/read/32750627/a-review-of-guidelines-on-anticoagulation-reversal-across-different-clinical-scenarios-is-there-a-general-consensus
#31
REVIEW
Truman J Milling, Charles V Pollack
Anticoagulation is key to the treatment/prevention of thromboembolic events. The primary complication of anticoagulation is serious or life-threatening hemorrhage, which may necessitate prompt anticoagulation reversal; this could also be required for nonbleeding patients requiring urgent/emergent invasive procedures. The decision to reverse anticoagulation should weigh the benefit-risk ratio of supporting hemostasis versus post-reversal thrombosis. We appraise the available guidelines/recommendations for vitamin K antagonist (VKA) and direct oral anticoagulant (DOAC) reversal in the management of major bleeding, and also assess recent clinical data that may not yet be reflected in official guidance...
September 2020: American Journal of Emergency Medicine
https://read.qxmd.com/read/32620199/therapeutic-approaches-in-the-treatment-of-gout
#32
REVIEW
Michael H Pillinger, Brian F Mandell
Gout is a disease in which the metabolic condition hyperuricemia leads to the formation of monosodium urate crystals, which provoke acute and chronic inflammatory responses through activation of the innate immune system. Recent advances in our knowledge of gout pathogenesis have emphasized the role of the kidneys in urate handling, the evolutionary loss of uricase as a necessary precondition for hyperuricemia, and the central role of IL-1ß in the pathogenesis of gouty inflammation. These, and other advances, have shaped our current strategies for managing gout...
June 2020: Seminars in Arthritis and Rheumatism
https://read.qxmd.com/read/32600375/update-of-the-treatment-of-nosocomial-pneumonia-in-the-icu
#33
REVIEW
Rafael Zaragoza, Pablo Vidal-Cortés, Gerardo Aguilar, Marcio Borges, Emili Diaz, Ricard Ferrer, Emilio Maseda, Mercedes Nieto, Francisco Xavier Nuvials, Paula Ramirez, Alejandro Rodriguez, Cruz Soriano, Javier Veganzones, Ignacio Martín-Loeches
In accordance with the recommendations of, amongst others, the Surviving Sepsis Campaign and the recently published European treatment guidelines for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), in the event of a patient with such infections, empirical antibiotic treatment must be appropriate and administered as early as possible. The aim of this manuscript is to update treatment protocols by reviewing recently published studies on the treatment of nosocomial pneumonia in the critically ill patients that require invasive respiratory support and patients with HAP from hospital wards that require invasive mechanical ventilation...
June 29, 2020: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/32488607/acute-metabolic-emergencies-in-diabetes-dka-hhs-and-edka
#34
JOURNAL ARTICLE
Muhammad Muneer, Ijaz Akbar
Emergency admissions due to acute metabolic crisis in patients with diabetes remain some of the most common and challenging conditions. DKA (Diabetic Ketoacidosis), HHS (Hyperglycaemic Hyperosmolar State) and recently focused EDKA (Euglycaemic Diabetic Ketoacidosis) are life-threatening different entities. DKA and HHS have distinctly different pathophysiology but basic management protocols are the same. EDKA is just like DKA but without hyperglycaemia. T1D, particularly children are vulnerable to DKA and T2D, particularly elderly with comorbidities are vulnerable to HHS...
2021: Advances in Experimental Medicine and Biology
https://read.qxmd.com/read/32339028/american-association-of-clinical-endocrinologists-american-college-of-endocrinology-clinical-practice-guidelines-for-the-diagnosis-and-treatment-of-postmenopausal-osteoporosis-2020-update-executive-summary
#35
JOURNAL ARTICLE
Pauline M Camacho, Steven M Petak, Neil Binkley, Dima L Diab, Leslie S Eldeiry, Azeez Farooki, Steven T Harris, Daniel L Hurley, Jennifer Kelly, E Michael Lewiecki, Rachel Pessah-Pollack, Michael McClung, Sunil J Wimalawansa, Nelson B Watts
Objective: The development of these guidelines is sponsored by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols for the standardized production of clinical practice guidelines (CPG). Methods: Recommendations are based on diligent reviews of the clinical evidence with transparent incorporation of subjective factors, according to established AACE/ACE guidelines for guidelines protocols...
April 27, 2020: Endocrine Practice
https://read.qxmd.com/read/32405775/new-criteria-for-lupus
#36
REVIEW
Martin Aringer, Nicolai Leuchten, Sindhu R Johnson
PURPOSE OF THE REVIEW: Classification criteria define the patient population for clinical trials and translational studies, but also influence current understanding of the disease. This review attempts to delineate the development from the American College of Rheumatology (ACR) 1982 to the European League Against Rheumatism (EULAR)/ACR 2019 classification criteria for systemic lupus erythematosus (SLE). RECENT FINDINGS: The new EULAR/ACR classification criteria use antinuclear antibodies (ANA) as an entry criterion...
May 13, 2020: Current Rheumatology Reports
https://read.qxmd.com/read/32423351/association-between-treatment-with-apixaban-dabigatran-rivaroxaban-or-warfarin-and-risk-for-osteoporotic-fractures-among-patients-with-atrial-fibrillation-a-population-based-cohort-study
#37
JOURNAL ARTICLE
Wallis C Y Lau, Ching-Lung Cheung, Kenneth K C Man, Esther W Chan, Chor Wing Sing, Gregory Y H Lip, Chung-Wah Siu, Joanne K Y Lam, Alan C H Lee, Ian C K Wong
BACKGROUND: It is unclear whether anticoagulant type is associated with the risk for osteoporotic fracture, a deleterious complication of anticoagulants among patients with atrial fibrillation (AF). OBJECTIVE: To compare the risk for osteoporotic fracture between anticoagulants. DESIGN: Population-based cohort study. SETTING: Territory-wide electronic health record database of the Hong Kong Hospital Authority. PARTICIPANTS: Patients newly diagnosed with AF between 2010 and 2017 who received a new prescription for warfarin or a direct oral anticoagulant (DOAC) (apixaban, dabigatran, or rivaroxaban)...
July 7, 2020: Annals of Internal Medicine
https://read.qxmd.com/read/32339046/evaluation-and-management-of-premature-ventricular-complexes
#38
REVIEW
Gregory M Marcus
Premature ventricular complexes (PVCs) are extremely common, found in the majority of individuals undergoing long-term ambulatory monitoring. Increasing age, a taller height, a higher blood pressure, a history of heart disease, performance of less physical activity, and smoking each predict a greater PVC frequency. Although the fundamental causes of PVCs remain largely unknown, potential mechanisms for any given PVC include triggered activity, automaticity, and reentry. PVCs are commonly asymptomatic but can also result in palpitations, dyspnea, presyncope, and fatigue...
April 28, 2020: Circulation
https://read.qxmd.com/read/32213097/angiotensin-converting-enzyme-2-a-double-edged-sword
#39
REVIEW
Kaiming Wang, Mahmoud Gheblawi, Gavin Y Oudit
No abstract text is available yet for this article.
August 4, 2020: Circulation
https://read.qxmd.com/read/32103284/severe-sars-cov-2-infections-practical-considerations-and-management-strategy-for-intensivists
#40
JOURNAL ARTICLE
Lila Bouadma, Francois-Xavier Lescure, Jean-Christophe Lucet, Yazdan Yazdanpanah, Jean-Francois Timsit
No abstract text is available yet for this article.
April 2020: Intensive Care Medicine
label_collection
label_collection
8038
2
3
2020-03-30 08:28:58
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.